Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05120349 |
|---|---|
| Brief Title: | A Global Study to Assess the Effects of Osimertinib in Participants With EGFRm Stage IA2-IA3 NSCLC Following Complete Tumour Resection (ADAURA2) |
| First Submitted : | November 3, 2021 |
| First Submitted that Met QC Criteria : | November 3, 2021 |
| First Posted : | November 15, 2021 |
| Last Update Submitted that Met QC Criteria : | April 23, 2024 |
| Last Update Posted : | April 24, 2024 |